CD274 and neoplasm: PD-1/PD-L1 expression level [25], tumor mutation burden (TMB) [13, 26], high microsatellite instability (MSI-H) [27], tumor infiltrating T cell content [28], and neutrophil-lymphocyte ratio (NLR) [29] are currently more widely accepted indicators of response efficacy.